SCHEMBL26324995

SCHEMBL26324995

CC(C)OC(=O)C(C(C)C)N(c1ccc(Oc2ccccc2)cc1)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.42
NPY5R Q15761 6/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ACACB O00763 1/20 0.42
ACACA Q13085 1/20 0.42
MMP9 P14780 2/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41
MMP14 P50281 1/20 0.41
MMP16 P51512 1/20 0.41
ADAM17 P78536 1/20 0.41
NPY2R P49146 1/20 0.40
SRD5A2 P31213 1/20 0.40
ALOX5 P09917 1/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26324957 0.99 PTGS1 (0.41) PTGS1NPY5RSMN1; SMN2ACACBACACA
SCHEMBL26324974 0.91 PTGS1 (0.39) PTGS1NPY5RSMN1; SMN2ACACBACACA
SCHEMBL26324800 0.88 TSHR (0.42) SMN1; SMN2MMP9MMP2MMP3MMP8
SCHEMBL26325014 0.85 PDCD1 (0.51) MMP9MMP1MMP2MMP3MMP8
SCHEMBL25439886 0.85 ALOX5 (0.45) PTGS1NPY5RSMN1; SMN2ACACBACACA
SCHEMBL25440264 0.84 ALOX5 (0.44) PTGS1NPY5RSMN1; SMN2ACACBACACA
SCHEMBL26324955 0.84 PDCD1 (0.50) MMP9MMP1MMP2MMP3MMP8
SCHEMBL26324940 0.84 TRPM8 (0.39) SMN1; SMN2MMP9MMP2MMP8MMP13
SCHEMBL26324999 0.80 ALOX5 (0.37) ALOX5ALDH1A1
SCHEMBL26324997 0.79 MEN1 (0.44) SMN1; SMN2MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 PTGS1 4470/4885NPY5R 2756/4885SMN1; SMN2 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.